Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 29, 1997

View Archived Issues

DepoTech: Q3 1997 highlights

Penwest: Q4 and FY 1997 highlights

Kyowa Hakko: Annual Report 1997

Tripos: Q3 1997 highlights

Antitumor effects of Techniclone's LYM-2 reported

FDA clears generic estradiol product

Lilly and Chugai enter into combinatorial chemistry collaboration

Apligraf comparable to autograft for donor site wounds

Diester prodrugs of antiviral acyclic nucleoside disclosed by Medivir

Biomeasure discloses protein farnesyltranserase inhibitors

Endothelin antagonists described by Bristol-Myers Squibb

New serine protease inhibitors for thrombotic disorders from Akzo Nobel

Shionogi presents potent and selective CCKB/gastrin receptor antagonist

Effects of NO donor ITF-1129 on blood flow/hemodynamics during myocardial ischemia

Advisory committee recommends approval for Plavix

Banyu discloses protein farnesyltransferase inhibitors

New ACAT inhibitors discovered at Mitsubishi Chemical

Update on Sano product pipeline

Pravachol now available in Canada for preventing a first heart attack

Differin is equieffective but better tolerated than Retin A in patients with acne

Bicalutamide + LHRH-A vs. flutamide + LHRH-A for metastatic prostate cancer

Hepatitis C-related technology available for licensing from NIH

Lyme disease diagnostic technology available for licensing

MuLV diagnostic kit available from NIH

FDA clears generic cimetidine

Gene therapy approach to preventing organ transplant complication explored

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...